Akademska digitalna zbirka SLovenije - logo
E-viri
Celotno besedilo
Recenzirano Odprti dostop
  • Ghrelin receptor modulates ...
    Di Giovangiulio, M.; Stakenborg, N.; Bosmans, G.; Meroni, E.; Farro, G.; Gomez‐Pinilla, P. J.; Depoortere, I.; Boeckxstaens, G. E.; Matteoli, G.

    Neurogastroenterology and motility, November 2015, Letnik: 27, Številka: 11
    Journal Article

    Background The orexigenic peptide ghrelin has anti‐inflammatory properties in colitis, however, the mechanism of action and the immune cells targeted remain still to be elucidated. Here, we assessed the possible effect of ghrelin on T helper (Th) cells in a T cell transfer model of chronic colitis. Methods Disease was induced in the recombination activating gene 1 knockout mice (Rag1−/−) by adoptive transfer of naïve Th cells from ghrelin receptor knockout mice (GRLN‐R−/−) or littermate wild‐type (WT) mice. The course and severity of colitis was assessed by monitoring body weight, diarrhea score, histological analysis, gene expression, and flow cytometry analysis. The possible effects of ghrelin on Th cell proliferation, polarization, and apoptosis was examined in vitro. Key Results Our data showed that Rag1−/− mice injected with GRLN‐R−/− Th cells displayed increased severity of colitis compared to mice injected with WT Th cells. In addition, Rag1−/− mice injected with GRLN‐R−/− Th cells had significantly higher intestinal inflammation and increased accumulation of Th1 and Th17 cells in the colon. In vitro, ghrelin directly affected proliferation of Th cells and induced apoptosis whereas it did not influence Th cell polarization. Conclusion & Inferences Our observations suggest that ghrelin modulates Th effector cells in the gut controlling proliferation and inducing apoptosis. Our findings further support the use of ghrelin as a novel therapeutic option to treat intestinal inflammatory diseases. The expression of the orexigenic hormone ghrelin and its receptor has been reported on various immune cells including T helper (Th) cells both in humans and rodents. Based on the above, and taking into account the large expression of ghrelin in the bowel mucosa, we hypothesized that this peptide may directly modulate intestinal Th cells during colonic inflammation. Hence, we used a well‐characterized model of Th cell‐induced chronic colitis that allowed us to study the influence of ghrelin receptor specifically on Th cells. In this study, we observed that the lack of ghrelin signaling in Th cells significantly worsens colitis with increased colonic inflammation. Our data revealed a specific immunomodulatory effect of ghrelin on Th cells, making the ghrelin receptor a suitable therapeutic candidate to treat chronic intestinal inflammatory diseases.